ACET Message Board Post 8896462 | Adicet Bio Inc.
home / stock / acet / acet message board
ayushjain1296
(investorshub)
Posted on: Dec/08/2021 14:58:31
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167046209
Phase 1's usually suck wind, I lost $80K
News, Short Squeeze, Breakout and More Instantly...
-
2025-02-05 08:44:04 ET DENVER, Colo., Feb 05, 2025 ( 247marketnews.com )- Adicet Bio (NASDAQ: ACET ) stated that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to ADI-001 for the potential treatment of adult patients with refractory systemic lupus erythem...
-
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Guggenh...
-
Adicet made significant progress in 2024 and is well-positioned for success in 2025: Advancing Phase 1 clinical trial evaluating ADI-001 across six autoimmune diseases; preliminary data in lupus nephritis (LN) patients anticipated in 1H25, data from other patient cohorts expected in 2H25 ...